Balata Gihan F, Abdelhady Mohamed I S, Mahmoud Ghada M, Matar Moustafa A, Abd El-Latif Amani N
Department of Pharmaceutics, Faculty of Pharmacy, Umm Al-Qura University, Makkah. Saudi Arabia.
Department of Pharmacognosy, Faculty of Pharmacy, Umm Al-Qura University, Makkah. Saudi Arabia.
Curr Drug Deliv. 2018;15(1):97-109. doi: 10.2174/1567201814666170125121735.
Propolis has been widely used to treat oral cavity disorders, such as endodontal and periodontal diseases and microbial infections.
The study aimed at the formulation of commercial Saudi propolis into biodegradable chitosan chips and evaluation of its effectiveness as a pulpotomy agent.
The standardization of 80% ethanolic propolis extract was performed regarding its total phenolic content, total flavonoid content, quantitative estimation of main polyphenolic constituents and antioxidant activity. Chitosan chips containing propolis extract were prepared by the solvent/ casting method. The investigated variables were % of chitosan polymer (2, 2.5 and 3%), % of plasticizer (1, 5 and 10%) and incorporation of different concentrations of hydroxypropyl methylcellulose (5, 10 and 20% of polymer weight). The chips were characterized for weight and thickness uniformity, content uniformity, pH, percentage moisture loss, swelling index, tensile strength and in vitro propolis release. The optimal propolis chip formulation was further investigated in dogs regarding the short term response of primary dental pulp to propolis chips compared with the most commonly used formocresol preparation.
The prepared films were flexible and demonstrated satisfactory physicochemical characteristics. The optimal formulation showed an initial release of about 41.7% of the loaded propolis followed by a sustained release extended up to 7 days. The kinetics study demonstrated that propolis release was controlled by Fick´s diffusion. The optimal propolis chip formulation resulted in less pulpal inflammation compared to formocresol, and produced hard tissue formation in all specimens.
Formulation of commercial Saudi propolis as a biodegradable chitosan chip is an effective alternative to the commercially available chemical agents for the treatment of vital pulpotomy.
蜂胶已被广泛用于治疗口腔疾病,如牙髓病和牙周病以及微生物感染。
本研究旨在将沙特商业蜂胶制成可生物降解的壳聚糖片,并评估其作为牙髓切断术药物的有效性。
对80%乙醇蜂胶提取物的总酚含量、总黄酮含量、主要多酚成分的定量测定及抗氧化活性进行标准化。采用溶剂浇铸法制备含蜂胶提取物的壳聚糖片。研究变量包括壳聚糖聚合物的百分比(2%、2.5%和3%)、增塑剂的百分比(1%、5%和10%)以及不同浓度羟丙基甲基纤维素的加入量(占聚合物重量的5%、10%和20%)。对该片剂的重量和厚度均匀性、含量均匀性、pH值、水分损失百分比、溶胀指数、拉伸强度及体外蜂胶释放情况进行表征。与最常用的甲醛甲酚制剂相比,进一步在犬身上研究了最佳蜂胶片制剂对乳牙牙髓的短期反应。
制备的薄膜柔韧性好,理化特性令人满意。最佳制剂显示,负载蜂胶的初始释放率约为41.7%,随后持续释放长达7天。动力学研究表明,蜂胶的释放受菲克扩散控制。与甲醛甲酚相比,最佳蜂胶片制剂导致的牙髓炎症较轻,且在所有标本中均形成了硬组织。
将沙特商业蜂胶制成可生物降解的壳聚糖片是治疗活髓切断术的一种有效替代商业化学药物的方法。